Available from Accessed 1 Mar 2023 Foster NC, Beck RW, Miller KM et al (2019) State of type 1 diabetes management and outcomes from the T1D exchange in 20162018
Upgrade from brush and floss to a three-step microhabit that takes two minutes more but cuts recurrence
Tirzepatide at therapeutic doses (10-15 mg) produces enough appetite suppression and weight loss that adding a stimulant provides minimal additional benefit while introducing unnecessary risks
Figure 1: Projected volume, selected GLP-1 brands, all payer channel Note: GLP-1 brands include Victoza, Trulicity, Saxenda, Ozempic, Rybelsus, Wegovy, and Mounjaro Source: Will improved outcomes offset the cost of treatment
NiceRx.com The Pharmaceutical Journal
Studies show that an individual can receive 1,000 milligrams of vitamin B12 as a sole ingredient each week